主持科研项目：
1. 国家自然科学基金青年项目，81703847，Wnt/β-catenin通路诱导非小细胞肺癌上皮间质转化调控ALK抑制剂耐药及黄连素对其作用研究，2018/01-2020/12，20万元，主持。
论著
1. Lihong Fan, Hao Chen,
Junliang Teng, Dan Li, Changhui Wang, Qing Xia, Bo Su and Huiwei Qi. Evaluation
of Serum-Paired miRNA Ratios for Early Diagnosis of Non-Small Cell Lung Cancer Using
Quantum Dot-Based Suspension Array. Journal of Nanomaterials 2018.
2. Lihong Fan, Jie Sha,
Junjie Teng, Dan Li, Changhui Wang, Qing Xia, Hao Chen, Bo Su and Huiwei Qi. Evaluation of serum paired miroRNA ratios for differential
diagnosis of non-small cell lung cancer and benign pulmonary diseases. Mol
Diagn Ther. 2018.
3. Lihong Fan, Huiwei Qi,
Junjie Teng, Bo Su, Hao Chen, Changhui Wang and Qing Xia. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for earlydetection of non-small cell lung cancer.
Tumour Biol 2016, 37(6): 7777-84.
4. Huiwei Qi, Lingyan
Xin, Xin Xu, Xianxiu Ji and Lihong Fan. Epithelial-to-mesenchymal transition
markers to predict response of Berberine in suppressing lung cancer invasion
and metastasis. J Transl Med 2014, 12: 22.
5. Jie Zhang, Huiwei Qi,
Yuping Sun, Huikang Xie, Caicun Zhou. Mosquito coil exposure associated with
small cell lung cancer: A report of three cases. Oncol lett
2015, 9(4): 1667-1671.
6. Huiwei Qi, Sen Jiang, Dong
Yu, Huijuan Ni, Qiong Hu, Jie Zhang. Continuing EGFR-TKI treatment in
combination with super-selective arterial infusion chemotherapy beyond disease
progression for patients with advanced EGFR-mutant non-small cell lung cancer.
Med Oncol, 2015,32(12)：256-256.
7. Jie Zhang, Huiwei Qi,
Hui Zheng, Mo Chen, Jun Zhu, HuiKang Xie, Jian Ni, Jian-Fang Xu, CaiCun Zhou. Etoposide-Cisplatin
Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in
Patients with Extensive Disease Combined Small Cell Lung Cancer. Asian Pac J Cancer
Prev, 2014, 15 (10): 4159-4163.
8. Huiwei Qi, Zan Shen
and Lihong Fan. Combined inhibition
of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a
human non-small cell lung cancer resistant cell line. Exp Ther Med, 2011,
2(6): 1091-1095.
Grant
Supports
Title:
Wnt/β-catenin induced epithelial-to-mesenchymal transition regulates ALK
inhibitor resistance in non-small cell lung cancer and the effects of
Berberine.
Funding
Source: The National Natural Science Fund (No. 81703847) 2018.01-2020.12
200,000
Publications
1.
Lihong Fan, Hao Chen,
Junliang Teng, Dan Li, Changhui Wang, Qing Xia, Bo Su and Huiwei Qi. Evaluation
of Serum-Paired miRNA Ratios for Early Diagnosis of Non-Small Cell Lung Cancer Using Quantum Dot-Based
Suspension Array. Journal of Nanomaterials 2018.
2.
Lihong Fan, Jie Sha,
Junjie Teng, Dan Li, Changhui Wang, Qing Xia, Hao Chen, Bo Su and Huiwei
Qi. Evaluation of serum paired miroRNA ratios for differential diagnosis of
non-small cell lung cancer and benign pulmonary diseases. Mol Diagn Ther. 2018.
3.
Lihong Fan, Huiwei
Qi, Junjie Teng, Bo Su, Hao Chen, Changhui Wang and Qing Xia. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for earlydetection of non-small cell lung cancer.
Tumour Biol 2016, 37(6): 7777-84.
4.
Huiwei Qi, Lingyan Xin, Xin Xu, Xianxiu Ji and
Lihong Fan. Epithelial-to-mesenchymal transition markers to predict response of
Berberine in suppressing lung cancer invasion and metastasis. J Transl Med
2014, 12: 22.
5.
Jie Zhang, Huiwei Qi,
Yuping Sun, Huikang Xie, Caicun Zhou. Mosquito coil exposure associated with
small cell lung cancer: A report of three cases. Oncol lett 2015, 9(4):
1667-1671.
6.
Huiwei Qi, Sen Jiang, Dong Yu, Huijuan Ni, Qiong Hu,
Jie Zhang. Continuing EGFR-TKI treatment in combination with super-selective
arterial infusion chemotherapy beyond disease progression for patients with
advanced EGFR-mutant non-small cell lung cancer. Med Oncol, 2015,32(12)：256-256.
7.
Jie Zhang, Huiwei Qi,
Hui Zheng, Mo Chen, Jun Zhu, HuiKang Xie, Jian Ni, Jian-Fang Xu, CaiCun Zhou. Etoposide-Cisplatin
Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in
Patients with Extensive Disease Combined Small Cell Lung Cancer. Asian Pac J
Cancer Prev, 2014, 15 (10): 4159-4163.
Huiwei Qi, Zan Shen and Lihong Fan. Combined
inhibition of insulin-like growth factor-1 receptor enhances the effects of
gefitinib in a human non-small cell lung cancer resistant cell line. Exp Ther
Med, 2011, 2(6): 1091-1095.
